Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Staphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a Review of the Literature

Figures & data

Table 1 Antibiotic Susceptibility Rates Among S. aureus Isolates Included in This Study

	CAI-SA			SSTI-SA			UTI-SA			Overall
	MSSA (n=50)	MRSA (n=50)	Overall (n=100)	MSSA (n=50)	MRSA (n=50)	Overall (n=100)	MSSA (n=50)	MRSA (n=50)	Overall (n=100)	MSSA (n=150)	MRSA (n=150)
Erythromycin	90% (n=45)	20% (n=10)	55% (n=55)	86% (n=43)	16% (n=8)	51% (n=51)	94% (n=47)	18% (n=9)	56% (n=56)	90% (n=135)	18% (n=27)
Clindamycin	84% (n=42)	14% (n==7)	49% (n=49)	80% (n=40)	10% (n=5)	45% (n=45)	86% (n=43)	14% (n==7)	50% (n=50)	83% (n=125)	13% (n=19)
Ciprofloxacin	92% (n=46)	14% (n==7)	48% (n=48)	90% (n=45)	10% (n=5)	50% (n=50)	90% (n=45)	8% (n=4)	49% (n=49)	91% (n=136)	11% (n=16)
Gentamicin	96% (n=48)	88% (n=44)	92% (n=92)	96% (n=48)	84% (n=42)	90% (n=90)	96% (n=48)	82% (n=41)	89% (n=89)	96% (n=144)	85% (n=127)
Sulfamethoxazole/trimethoprim	96% (n=48)	80% (n=40)	88% (n=88)	92% (n=46)	84% (n=42)	88% (n=88)	96% (n=48)	88% (n=44)	92% (n=92)	95% (n=142)	84% (n=126)
Vancomycin	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)
Tigecycline	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)
Linezolid	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)
Fusidic acid	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)
Quinpristin/dalfopristin	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)
Rifampin	90% (n=45)	80% (n=40)	85% (n=85)	88% (n=44)	80% (n=40)	84% (n=84)	92% (n=46)	84% (n=42)	86% (n=86)	90% (n=135)	81% (n=122)
Ceftaroline	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=50)	100% (n=50)	100% (n=100)	100% (n=150)	100% (n=150)

Abbreviations: MSSA, methicillin-resistant S. aureus; MRSA, methicillin-resistant S. aureus; CAI-SA, catheter-associated infections; SSTI-SA, skin and soft tissue infections; UTI-SA, urinary tract infections.

Figure 1 Antibiotic susceptibility rates among S. aureus isolates included in this study.

Abbreviations: MSSA, methicillin-resistant S. aureus; MRSA, methicillin-resistant S. aureus; CAI-SA, catheter-associated infections; SSTI-SA, skin and soft tissue infections; UTI-SA, urinary tract infections.